Institution statistics

SANOFI PASTEUR SA - France 

This institution has been merged with: SANOFIAVENTIS.

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 25.810.243 0 3
2016 0 51.038.522 85.000 3
2010 0 11.460.630 100.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
GLAXOSMITHKLINE BIOLOGICALS5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
ISTITUTO SUPERIORE DI SANITA3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE2
ASTRAZENECA AB2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DEPARTMENT OF HEALTH2
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANIISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO2
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT2
PFIZER LIMITED2
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE LIBRE DE BRUXELLES2
UNIVERSITEIT ANTWERPEN2
ABBOTT BIOLOGICALS BV1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION PACCI1
AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY1
BIOMERIEUX1
BOEHRINGER INGELHEIM VETMEDICA1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST1
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC1
CONFEDERATION OF MENINGITIS ORGANISATIONS1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DA VOLTERRA SAS1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN VACCINE INITIATIVE EWIV1
EUROVACC FOUNDATION1
FIT BIOTECH OY1
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS1
FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA1
FRED HUTCHINSON CANCER RESEARCH CENTER NON PROFIT CORPORATION1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GENOME RESEARCH1
GOETEBORGS UNIVERSITET1
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH1
HEALTH SCIENCES ETRAINING FOUNDATION1
HEINRICHPETTE INSTITUT LEIBNIZ INSTITUT FUER EXPERIMENTELLE VIROLOGIE1
HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA1
INSERM TRANSFERT1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT PASTEUR1
INSTITUT PASTEUR DE LILLE1
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE1
INSTITUTE OF MICROBIOLOGY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC1
INSTITUTO NACIONAL DE SAUDE1
INTERNATIONAL AIDS VACCINE INITIATIVE INC1
INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH1
INTERVET INTERNATIONAL BV1
JANSSEN PHARMACEUTICA NV1
JANSSEN VACCINES & PREVENTION BV1
KAROLINSKA INSTITUTET1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN1
MEDICAL RESEARCH COUNCIL1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERIAL SAS1
NACIONALNI LABORATORIJ ZA ZDRAVJE OKOLJE IN HRANO1
NATIONAL INSTITUTE FOR MEDICAL RESEARCH1
NOVAVAX INC1
P95 CVBA1
PFIZER MANUFACTURING AUSTRIA1
QBIOLOGICALS NV1
SCIENSANO1
SEQIRUS UK LIMITED1
SERVIZO GALEGO DE SAUDE1
STATENS SERUM INSTITUT1
STICHTING HOGESCHOOL UTRECHT1
STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS1
STICHTING KATHOLIEKE UNIVERSITEIT1
TEL AVIV UNIVERSITY1
TERVEYDEN JA HYVINVOINNIN LAITOS1
THE GENERAL HOSPITAL CORPORATION1
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
TURUN YLIOPISTO1
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION1
UNITED KINGDOM RESEARCH AND INNOVATION1
UNIVERSIDAD DE SALAMANCA1
UNIVERSITA DEGLI STUDI DI FIRENZE1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITAET BERN1
UNIVERSITAET REGENSBURG1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
Constancy:

Total number of partners:147

Partner loyalty:
Frequent Partner: (> 2 projects): 20
Rare Partner: 127

Frequent / Rare Partner Ratio: 0.16

Diversity:

Subjects: Diversity index:1
Categories:
Category:No:
BIOLOGICAL SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-07-01Development of Robust and Innovative Vaccine Effectiveness DRIVEparticipant8.999.81315
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-03-01PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 PERISCOPEparticipant21.000.00024
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52243
2010-11-01"Vaccination against Shigella and ETEC: novel antigens, novel approaches" STOPENTERICSparticipant11.460.63017
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum